u/emeka_delgado

I would not round that figure. At 5mg/mL a rounding error of two units is a real fraction of the intended amount.

prior authorisation criteria change every plan year

Have you asked for the clinical policy bulletin by number?

deadlines run from the letter date, not from when you opened it

Yes — reconstitution date on the vial. It is the number you will want and cannot reconstruct.

That figure is a private price at one pharmacy, not a national one.

label the vial with the date as well as the concentration

Was there a logger in the box?

write the concentration on the vial in marker, that is the whole post

Yes — quoting their own policy bulletin back at them is far more effective than arguing in general terms.

I would not freeze it in solution. That is a different failure mode and a worse one.

ask for the denial reason in writing, always

Correction: that is the oral peptide product, which is a different thing entirely. This one is a small molecule.

keep every date, every reference number, every name of a department

Milligram comparisons across molecule classes are meaningless.

Agreed, and it is why the oral peptide comparison keeps misleading people.

Once in solution, the relevant risks are hydrolysis, aggregation and, for some sequences, oxidation. Refrigeration slows all three; freezing a solution introduces a separate risk at the ice interface.

Milligram-for-milligram comparison with an injectable peptide is not meaningful and I should not have made it.

the door shelf is the worst place in the fridge

Small fix — external review is independent of the plan. The second-level internal appeal is not.

Cosigning on asking the pharmacy to check the wholesaler. It converts speculation into a fact in one phone call.

Asked SGN what volume they reconstitute to for their own stability testing and they answered in one line. Useful thing to know.

phase 3 is where the comparison becomes fair

the price you pay depends on the listing status of your indication

Gel packs are designed for a duty cycle. A liquid pack at the end of a longer-than-expected transit is a pack behaving as specified, not evidence of an excursion in the vial.

Right, and keeping every date and reference number turns a frustrating process into an auditable one.

the powder cake sits at the bottom, the volume you add is the volume that counts

ask for the clinical policy bulletin by number

a peer-to-peer call is often faster than a written appeal

That is the ambient temperature at the destination, not the temperature inside the box. The logger measures the second one.

I would not freeze it in solution. That is a different failure mode and a worse one.

Push back: your plan is an employer plan, which changes both the appeal path and who the regulator is.

This. Step therapy is a paperwork requirement and it is beaten with documentation, not persuasion.

Push back: your plan is an employer plan, which changes both the appeal path and who the regulator is.

Adding the underused one — external review. Independent, binding where it applies, and hardly anybody gets that far.

This. Showing the working is the fastest way for somebody else to spot the mistake.

PBS-subsidised or private script?

Research-use-only material is not approved for human use, so treat everything in this thread as arithmetic about solutions rather than instructions for a person.

Peer-to-peer took fifteen minutes and resolved something a written appeal had been sitting on for a month.

Regional stock changes the question rather than answering it: shorter lanes mean less exposure and fewer variables, which is why the warehouse question is worth asking before ordering in summer.

Put a logger in three consecutive orders. Two never went above the range at all and the third spent four hours warm on a Friday. Cost me almost nothing to stop wondering.

regional stock removes most of this problem entirely